Latest Insider Transactions at Cognition Therapeutics Inc (CGTX)
This section provides a real-time view of insider transactions for Cognition Therapeutics Inc (CGTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of COGNITION THERAPEUTICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of COGNITION THERAPEUTICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 13
2021
|
Bios Memory Spv I, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
90
-0.02%
|
$1,080
$12.0 P/Share
|
|
Oct 13
2021
|
Bios Memory Spv I, LP > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
33,495
+8.0%
|
$0
$0.03 P/Share
|
|
Oct 13
2021
|
Bios Memory Spv I, LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,424,014
+50.0%
|
-
|
|
Oct 13
2021
|
James Michael O'Brien Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$60,000
$12.0 P/Share
|
|
Oct 13
2021
|
Lisa Ricciardi CEO & President |
BUY
Open market or private purchase
|
Direct |
12,500
+50.0%
|
$150,000
$12.0 P/Share
|